Medtronic received information that prior to the implant of this transcatheter bioprosthetic valve after obtaining bilateral femoral access and using standard exchanges, a super stiff lunderquist guidewire was inserted into the left ventricle.The patient became tachycardic and hypotensive.Aortogram verified there was no wire perforation nor trauma to the aortic root and abdominal aorta.The patient was intubated and transesophageal echocardiogram (tee) verified there was no pleural effusion and revealed severe mitral regurgitation.A coronary angiogram showed the right coronary artery was widely patent.The blood pressure began to drop and the valve was implanted at 3mm on the non-coronary cusp and 4mm on the left coronary cusp.An intra-aortic balloon pump was initiated with no effect on the blood pressure.The cardiac rhythm converted to ventricular fibrillation and the cardiopulmonary resuscitation (cpr) was performed.The patient was shocked several times and expired on the table.The family requested that no autopsy be performed.(b)(4).This report reflects information received by fda in the form of a notification per 803.22 (b)(2).
|